[HTML][HTML] Type I Interferons in Systemic Autoimmune Rheumatic Diseases: Pathogenesis, Clinical Features and Treatment Options

K Drougkas, C Skarlis… - Mediterranean Journal of …, 2024 - pmc.ncbi.nlm.nih.gov
Type I interferon (IFN) pathway dysregulation plays a crucial role in the pathogenesis of
several systemic autoimmune rheumatic diseases (SARDs), including systemic lupus …

Biomarkers of lymphoma in Sjögren's syndrome: what's the latest?

IE Stergiou, AD Bakasis, S Giannouli… - Expert Review of …, 2022 - Taylor & Francis
ABSTRACT Introduction Primary Sjögren's syndrome (pSS) is a chronic autoimmune
disease standing in the crossroads of autoimmunity and lymphomagenesis, characterized …

Autoantibodies identify primary Sjögren's syndrome in patients lacking serum IgG specific for Ro/SS-A and La/SS-B

S Longobardi, C Lopez-Davis, B Khatri… - Annals of the …, 2023 - ard.bmj.com
Objective Identify autoantibodies in anti-Ro/SS-A negative primary Sjögren's syndrome (SS).
Methods This is a proof-of-concept, case-control study of SS, healthy (HC) and other disease …

[HTML][HTML] Autoimmune rheumatic diseases: One or many diseases?

HM Moutsopoulos - Journal of Translational Autoimmunity, 2021 - Elsevier
Until the etiopathogenic factor (s) of autoimmune and autoinflammatory rheumatic disorders
will be identified, their classification into entities will continue. However, their similar clinical …

[PDF][PDF] Interferon-alpha regulates expression of lncRNA MALAT1 and interferon-stimulated genes, as well as chemokine production, in primary Sjögren's syndrome

LM Amezcua-Guerra, F Sánchez-Muñoz… - Clin. Exp …, 2022 - clinexprheumatol.org
Interferon-alpha regulates expression of lncRNA MALAT1 and interferon-stimulated genes, as
well as chemokine production, in prim Page 1 Clinical and Experimental Rheumatology 2018 …

Rapamycin can alleviate the submandibular gland pathology of Sjögren's syndrome by limiting the activation of cGAS–STING signaling pathway

W Zhu, Y Wang, Y Guan, Y Lu, Y Li, L Sun… - …, 2024 - Springer
Background Sjögren's Syndrome (SS) is also known as autoimmune exocrine gland
disease. Previous studies have confirmed that adaptive immunity plays an important role in …

Involvement of expanded cytotoxic and proinflammatory CD28null T cells in primary Sjögren's syndrome

C Deng, A Wang, W Li, L Zhao, J Zhou, W Zhang… - Clinical …, 2024 - Elsevier
Objective The absence of CD28 is a feature of antigen-experienced, highly differentiated
and aged T cells. The pathogenicity of CD28 null T cells remains elusive in primary …

+ 3179G/A insulin-like growth factor-1 receptor polymorphism: a novel susceptibility contributor in anti-Ro/SSA positive patients with Sjögren's syndrome: potential …

C Skarlis, N Marketos, A Nezos… - Journal of Clinical …, 2021 - mdpi.com
Background: Alterations of the insulin-like growth factor (IGF) pathway along with genetic
variations of the IGF1 receptor (IGF1R) gene have been linked to the development of …

Transcriptomic Profiling of Peripheral B Cells in Antibody Positive Sjogren's Patients Reveals Interferon Signature

M Maleki-Fischbach, K Anderson, ER Fernández Pérez - Genes, 2024 - mdpi.com
Background: Sjögren's disease (SjD) is a common systemic autoimmune disease that affects
mainly women. Key pathologic features include the infiltration of exocrine glands by …

Predisposing Factors, Clinical Picture, and Outcome of B-Cell Non-Hodgkin's Lymphoma in Sjögren's Syndrome

IE Stergiou, AV Goules, M Voulgarelis, AG Tzioufas - Immuno, 2022 - mdpi.com
Among other systemic autoimmune diseases, primary Sjögren syndrome (pSS) bears the
highest risk for lymphoma development. In pSS, chronic antigenic stimulation gradually …